ArticleFrontiers in cardiovascular medicine2025

Single-centre, single-blind, randomized, active-controlled phase-3 non-inferiority study to investigate the safety and efficacy of the cardioplegic solution Cardioplexol™.

Hendrik T Tevaearai Stahel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.